Cowen and Company

Boston Beer Company Inc (NYSE: SAM), an early pioneer and current leader in the craft beer space, has been hit hard by the rise in popularity and increasing competition of the multitude of craft brewery’s over the past few years. With shares down nearly 20 percent year to date, fundamental...

Apple Inc. (NASDAQ: AAPL) shares currently trading at “about the same absolute multiple it peaked at in mid-2014 ahead of iPhone 6 launch,” according to Cowen’s Timothy Arcuri. The analyst believes that on a relative basis, the stock is still trading “at a much larger...

On Tuesday, Western Digital Corp (NASDAQ: WDC) will host its first investor day since acquiring SanDisk in May, and Cowen and Company analyst Karl Ackerman said it's one investors “don’t want to miss.” Leading in, Ackerman maintains an Outperform rating and $70 price target for...

Cowen’s Oliver Chen believes a large part of the pressure being faced by Lululemon Athletica inc. (NASDAQ: LULU) recently has been driven by fears regarding comps and margin due to higher-than-expected discounting. Chen maintains an Outperform rating on the company, while lowering the price...

Cowen and Company listed two positives and three negatives from Core Laboratories N.V. (NYSE: CLB)'s third-quarter results announcement. The company's results and the downbeat forecast for the fourth quarter dampened investors' sentiments on the stock. Analysts Marc Binachi and Vaibhav Vaishnav,...

Sarepta Therapeutics Inc (NASDAQ: SRPT) hosted a conference call Tuesday to discuss its newly approved drug, Exondys 51 (eteplirsen) injection, which happens to be the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Sarepta said Exondys 51 will be available in a...

Shares of Nike Inc (NYSE: NKE) have lost around 10 percent since the start of 2016 and are nearly flat compared to the same time period a year ago. The stock's underperformance isn't deterring John Kernan of Cowen and Company from reiterated an Outperform rating and $63 price target. In a research...

Cowen’s Jeffrey Osborne believes that while Tesla Motors Inc (NASDAQ: TSLA) appears well positioned fundamentally for the long term, there a significant execution risks over the next 12 to 18 months. Osborne initiated coverage of the company with an Underperform rating and price target of...

Cowen’s Jeffrey Osborne mentioned that Itron, Inc. (NASDAQ: ITRI) reported robust quarterly results, reflecting margin expansion and top-line growth. Osborne maintains a Market Perform rating on the company, while raising the price target from $45 to $50. “The company announced a...

Cowen’s Cai von Rumohr mentioned Smith & Wesson Holding Corp (NASDAQ: SWHC) continued its beat and raise record with Q1. Von Rumohr maintains an Outperform rating on the company with a price target of $34. Q1 Beat The company reported its GAAP EPS for Q1 at $0.57, ahead of the estimate...

Delta Air Lines, Inc. (NYSE: DAL) suffered from an embarrassing system-wide outage last week that affected its entire operations. Related Link: Delta Deals With System-Wide Outage; Investors Sell The News Delta quickly fixed the issues which plagued its system, but it is still unclear the financial...

Cowen and Company started coverage on Audentes Therapeutics Inc (NASDAQ: BOLD) with an Outperform rating, citing the strong pipeline and the bold steps taken entering into rare disease gene therapy. Analyst Ritu Baral stated the rating was backed by pipeline assets like AT132, AT342 and AT982 and...

NetSuite Inc (NYSE: N) shares rallied more than 10 percent on press speculations that Oracle Corporation (NYSE: ORCL) was interested in acquiring the company. However, Cowen’s J. Derrick Wood maintains an Underperform rating on NetSuite, with a price target of $70, citing the unlikeliness of...